Back
Larimar Therapeutics, Inc. Stock Predictions
Safe Investing Checklist - Stay Clear of Risky Stocks
Get Your Free Safe Stock Selector Checklist Now
Sell
46
LRMR
Larimar Therapeutics, Inc.
Last Price:
$3.81
Seasonality Move:
40.5%
7 Day Trial
ALL ACCESS PASS
$
7
Get Your Free Stock Selector Checklist and Invest Smarter
Get Your Free Safe Stock Selector Checklist NowLarimar Therapeutics, Inc. Stock Forecast
-
Is Larimar Therapeutics, Inc. Stock Undervalued?The current Larimar Therapeutics, Inc. [LRMR] share price is $3.70. The Score for LRMR is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
-
LRMR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Larimar Therapeutics, Inc. Stock Go Up Next Year?
Data Unavailable
Larimar Therapeutics, Inc. Stock Rating
Data Unavailable
Larimar Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
larimartx.com
52-Week Data
52-Week High:
6.91
52-Week Low:
1.61
Prediction Charts
Market Cap:
316.7M
Price in USD:
3.70
Volume:
623.7K
Beta:
0.65
Technical Analysis
SMA50:
3.90
SMA100:
3.88
SMA200:
3.20
52-Wk Change:
-38.54%
Stock Predictions
-
Is Larimar Therapeutics, Inc. stock public?Yes, Larimar Therapeutics, Inc. is a publicly traded company.
-
What is the Larimar Therapeutics, Inc. stock quote today?The Larimar Therapeutics, Inc. stock price is 3.70 USD today.
-
How to buy Larimar Therapeutics, Inc. stock online?You can buy Larimar Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-17 | 3.38 | 3.53 | 3.62 | 3.31 |
| Nov-18 | 3.49 | 3.39 | 3.64 | 3.37 |
| Nov-19 | 3.38 | 3.47 | 3.52 | 3.32 |
| Nov-20 | 3.55 | 3.37 | 3.68 | 3.33 |
| Nov-21 | 3.34 | 3.56 | 3.64 | 3.32 |
| Nov-24 | 3.52 | 3.66 | 3.68 | 3.51 |
| Nov-25 | 3.64 | 3.67 | 3.79 | 3.60 |
| Nov-26 | 3.68 | 3.53 | 3.73 | 3.52 |
| Nov-28 | 3.57 | 3.54 | 3.62 | 3.52 |
| Dec-1 | 3.48 | 3.55 | 3.69 | 3.40 |
| Dec-2 | 3.56 | 3.12 | 3.56 | 3.12 |
| Dec-3 | 3.20 | 3.47 | 3.49 | 3.14 |
| Dec-4 | 3.43 | 3.68 | 3.75 | 3.36 |
| Dec-5 | 3.72 | 3.70 | 3.80 | 3.66 |
Larimar Therapeutics, Inc. Earnings
Data Unavailable
Larimar Therapeutics, Inc. Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.78 per share, and an increase next year of $0.17 per share.
* Larimar Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.